Skip to main content

Pharma News

 

Clinical courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Patients suffering from drug-resistant tuberculosis may soon have access to Delamanid, one of two new drugs to get approval for the treatment of tuberculosis after more than 40 years. The drug was added to the kitty shrinking choices to treat multi-drug resistant (MDR) and resistant to resistant tuberculosis (XDR) shortly after bedaquiline.

  • The NPPA drug price regulator has reduced the prices of anticancer drugs by almost 86% since last March to relieve patients. There has been "a significant reduction in the prices of cancer drugs since March 2016," said the National Pharmaceutical Pricing Authority (NPPA) in a tweet.

  • The results of the recent Family Health Survey (NFHS 4) reveal that more than 58 percent of children under five are anemic, ie they suffer from hemoglobin deficiency Blood , Leaving them exhausted, vulnerable to infections, and possibly affecting their development.

    According to the World Health Organization, high levels of these markers are clear indications of poor socio-economic conditions and suboptimal health and / or nutritional conditions. In short, lack of food, unhealthy living conditions and poor health care delivery systems.

    According to 2011 census data, the total number of children under five in India in 2015 is estimated at 12.4 crore. Thus, about 7.2 crore children are anemic, nearly 5 crore are stunted, about 2.6 crore are wasted and 4.4 crore are underweight. These figures are not too different from those for 2005-2006. Since the population has grown, their share is down.

    The survey, which was conducted in 2015-16 and covered six lakh households, also showed that about 38% of children in the same age group were stunted, 21% were wasted and 36% were underweight. Although all internationally accepted markers of child health have improved since the last survey in 2005-2006, levels of undernutrition, mainly caused by poverty, are still high and improvement is too slow.


    The survey also found that just over half of all pregnant women were anemic. This automatically translates into their newborn being low. Overall, 53% of women and 23% of men aged 15-49 were anemic.

    There are wide variations between states. UP data has not been published due to ongoing surveys, according to Balram Paswan, a professor at the International Institute of Population Sciences in Mumbai, which was the nodal agency for the ministry's survey Of Health. But poorer states like Bihar, Madhya Pradesh, Jharkhand, Assam, Rajasthan and Chhattisgarh have rates above the national average rates on all markers. In Tamil Nadu, 51% of children are anemic while in Kerala, it is more than a third. In many states, stunting has decreased, but the proportion of severely wasted children has increased.


    The more advanced states such as those in the south, Haryana and Gujarat have slightly better numbers, but are still at unacceptably high levels. These are clear signs of an endemic hunger crisis in the country that policy makers do not seem to address.

    << Back to Pharma News

    Subscribe to PharmaTutor News Alerts by Email

  • As stipulated in the Decree on Drugs (Price Control) 2013, the NPPA sets the ceiling price for essential drugs in Schedule I. According to the National Pharmaceutical Pricing Authority (NPPA), "few" drugs will be taken care of as part of patient relief measures.

  • Allowing insurers to market healthcare policies across state lines is one of President Donald Trump's main ideas to cut costs. While supporters of the idea cast it as a way to make insurance policies more competitive, critics say it's unlikely to result in more affordable plans and could undermine stronger consumer protections in states such as California and Hawaii. Such a "race to the bottom" could leave some older consumers with health problems unable to afford coverage.

  • ICRA expects annual revenue growth of 12-14 percent over the next five years in the health care sector, in line with the trend over the last three years. The health care sector is expected to grow by 12 to 14 percent annually over the next five years, due to increased medical tourism and penetration of health insurance, rating agency ICRA said.

  • In a letter to Prime Minister Narendra Modi, the Alliance of Doctors for Ethical  Healthcare (ADEH) said that these drugs and implants are also accused of "exorbitantly" like coronary stents. ADEH has also attached documents to show how drug providers, especially those for cancer, and knee and hip replacement implants are exorbitant prices, sometimes 200 percent more than the actual price.

Subscribe to Pharma News